Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-151218
Filing Date
2021-12-17
Accepted
2021-12-17 17:04:15
Documents
1
Period of Report
2021-12-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2135659-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2135659-5_4seq1.xml 4 3585
  Complete submission text file 0001104659-21-151218.txt   5304
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

EIN.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1350 AVENUE OF THE AMERICAS NEW YORK NY 10019
Business Address
TAUB MALCOLM S (Reporting) CIK: 0001305117 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36641 | Film No.: 211502440